Objective: To evaluate the safety and feasibility of vaginal trial production after re-pregnancy in women with a single cesarean section history. Methods: Retrospective analysis of 75 pregnant women who were single caesarean section and gave birth in the First Hospital of Shanxi Medical University from October 2017 to October 2018, 31 of them were established as a vaginal delivery group, and 44 patients were set up as a cesarean section for caesarean section delivery. A further 40 cases of vaginal delivery of single pregnancy in the same period were selected as control group. Valuate the delivery conditions, the neonatal conditions and postpartum complications. Results: There was a statistically significant difference between cervical Bishop score, time-birth hemorrhage, hospitalization time, hospitalization cost, neonatal weight between cesarean section group and the vaginal delivery group (P<0.05). However, there were no significant differences between vaginal production and control group (P>0.05). Conclusion: Combined with the prenatal examination, admission and willingness of patients, it is safe and feasible to give scar uterus through vaginal delivery under strict evaluation and strict supervision. But before trial production, it must be informed of its success rate and the risk of uterine rupture.